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Abstract
Background: The American Association of Clinical Endocrinologists (AACE) current recommendation is
1000-1200 mg calcium daily for postmenopausal and osteoporotic women. Some patients are reluctant to
supplement calcium due to the fear of developing a kidney stone (nephrolithiasis). In the United States, every
adult will have a 10% to 15% chance to get kidney stones in their lifetime. And the recurrence rate is up to 50%
after 10 years. There is no clear theory on how kidney stones are formed. There are lots of factors that play into
the role of kidney stone generation, such as urinary calcium, oxalate, citrate, phosphate, and pH levels. About
75% of kidney stones are calcium oxalate stones. And most patients with calcium oxalate stones are
hypercalciuric and hyperoxaluric.Calcium supplements can increase calcium excretion in the urine, and in
theory can increase the risk of calcium kidney stones. The purpose of this review is to find out if calcium
supplementation does indeed increase risk of kidney stones in postmenopausal women.
Methods: An exhaustive search was conducted using Medline-OVID, Medline-PubMed, CINAHL, and Web
of Science using the keywords: calcium supplementation, kidney calculi and postmenopausal women.
Relevant articles were assessed for quality using GRADE.
Results: The initial search yielded 19 articles for review. After additional reading of the abstracts, two studies
met inclusion criteria and were included in this systematic review. These articles include one randomized
controlled trial and one observational study.
Conclusion: According to the results from the two studies and data collected, calcium supplementation in
postmenopausal women does not increase the risk of calcium oxalate kidney stones. Also postmenopausal
patients who had an incidence of kidney stones in the past should not be discouraged from taking calcium
supplements to prevent them from having osteoporosis. Dietary and supplemental calcium intake in these
studies seems to actually decrease the risk of kidney stone formation.
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Abstract   
Background: The American Association of Clinical Endocrinologists (AACE) current 
recommendation is 1000-1200 mg calcium daily for postmenopausal and osteoporotic women. 
Some patients are reluctant to supplement calcium due to the fear of developing a kidney stone 
(nephrolithiasis). In the United States, every adult will have a 10% to 15% chance to get kidney 
stones in their lifetime. And the recurrence rate is up to 50% after 10 years. There is no clear 
theory on how kidney stones are formed. There are lots of factors that play into the role of 
kidney stone generation, such as urinary calcium, oxalate, citrate, phosphate, and pH levels. 
About 75% of kidney stones are calcium oxalate stones. And most patients with calcium oxalate 
stones are hypercalciuric and hyperoxaluric. Calcium supplements can increase calcium 
excretion in the urine, and in theory can increase the risk of calcium kidney stones. The purpose 
of this review is to find out if calcium supplementation does indeed increase risk of kidney 
stones in postmenopausal women. 
Methods:  An exhaustive search was conducted using Medline-OVID, Medline-PubMed, 
CINAHL, and Web of Science using the keywords: calcium supplementation, kidney calculi and 
postmenopausal women. Relevant articles were assessed for quality using GRADE.  
Results:  The initial search yielded 19 articles for review. After additional reading of the 
abstracts, two studies met inclusion criteria and were included in this systematic review. These 
articles include one randomized controlled trial and one observational study.  
Conclusion:  According to the results from the two studies and data collected, calcium 
supplementation in postmenopausal women does not increase the risk of calcium oxalate kidney 
stones. Also postmenopausal patients who had an incidence of kidney stones in the past should 
not be discouraged from taking calcium supplements to prevent them from having osteoporosis. 
Dietary and supplemental calcium intake in these studies seems to actually decrease the risk of 
kidney stone formation. 
Keywords:  calcium supplementation, kidney calculi, postmenopausal women 
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Postmenopausal Women 
BACKGROUND 
“Osteoporosis is a generalized skeletal disorder characterized by compromised bone 
strength, which causes its sufferers to be predisposed to an increased risk of fractures.”1 
Postmenopausal women are prone to osteoporosis due to the loss of estrogen’s effect on bones. 
At the time of the Surgeon General’s report in 2004, an estimated 8 million women were 
affected.1,2 According to current recommendations, daily 1200mg calcium and 800 IU vitamin D 
are advised in postmenopausal women with osteoporosis.3 At the same time, the American 
Association of Clinical Endocrinologists (AACE) current recommendation is 1000-1200 mg 
calcium daily for postmenopausal and osteoporotic women. However, they recommend dietary 
calcium over supplemental calcium medication.4 Some patients are reluctant to supplement 
calcium due to the fear of developing a kidney stone (nephrolithiasis), and with all the divergent 
recommendations and guidelines, the first thing a clinician must keep in mind is to do no harm. 
              Kidney stones are quite common.5 In the United States, every adult will have a 10% to 
15% chance to get kidney stones in their lifetime.6-8 And the recurrence rate is up to 50% after 10 
years.5,9 There is no clear theory on how kidney stones are formed. But it was proposed that it’s 
due to urine supersaturation.10 There are many factors that play into the role of kidney stone 
generation, such as urinary calcium, oxalate, citrate, phosphate, and pH levels. About 75% of 
kidney stones are calcium oxalate stones.5 And most patients with calcium oxalate stones are 
hypercalciuric and hyperoxaluric. It is known that urinary calcium and oxalate both play a critical 
role in calcium oxalate stone formation.11 Nevertheless, it still remains controversial whether 
calcium or oxalate is more important in the supersaturation of urinary calcium oxalate.11-14  
              Calcium supplements can increase calcium excretion in the urine, and in theory can 
increase the risk of calcium kidney stones. The purpose of this review is to find out if calcium 
supplementation does indeed increase risk of kidney stones in postmenopausal women. Is it safe 
to recommend calcium supplementation to postmenopausal women without putting them at a 
greater risk of kidney stones?  
METHODS 
              An exhaustive search was conducted using Medline-OVID, Medline-PubMed, CINAHL 
and Web of Science using the keywords: calcium supplementation, kidney calculi and 
postmenopausal women. Relevant articles were assessed for quality using Grading of 
Recommendations, Assessment, Development and Evaluation (GRADE).15 
RESULTS 
The initial search yielded 19 articles for review. After additional reading of the abstracts, 
two studies met inclusion criteria and were included in this systematic review. These articles 
include one randomized controlled trial16 and one observational study17. See Table I.  
Domrongkitchaiporn et al Trial 
This randomized trial16 with 53 Thai women who were more than 10 years 
postmenopausal were selected in order to evaluate if supplemental calcium would increase risk 
of calcium oxalate stones. Risk of calcium oxalate stone formation was assessed by using the 
Tiselius’s index called AP(CaOx).18 AP(CaOx) was calculated before and after 3 months of daily 
supplementation with 750 mg calcium alone or with 0.5ug calcitriol.16 
Study population mean age was 65.3+/- 1.1 years, and enrollment criteria included 10 
years postmenopausal with osteoporosis. Patients who were currently on medications such as 
bisphosphonates, diuretics, vitamin D, or hormones were excluded from the study due to their 
effects on calcium balance. Patients were randomly assigned to receive either 250 mg calcium 
alone at the end of 3 meals everyday (group C) or with 0.25 ug calcitriol after breakfast and 
dinner (group CD). The treatment groups’ total energy intake, subdivided into carbohydrate, fat, 
protein, sugar, crude fiber content, was calculated at the beginning of the study, and the 
participants were told to maintain their normal diet during the 3 months period.16  
At the end of the study, 24-hour urine was collected to measure its volume and 
components including calcium, magnesium, citrate, sodium, potassium, oxalate, phosphate and 
creatinine. Then the AP(CaOx) was calculated using the following formula of AP(CaOx) index= 
A x Ca0.84 x Ox1.0 x Mg-0.12 x Cit-0.22 x V-0.13.18 Authors used AP( CaOx) index as an measurement 
of risk of calcium oxalate kidney stones formation due to the relationship and correlation that has 
been established and clinically proven.19-22 And an AP(CaOx) greater than 2.0 is related to an 
increased risk of calcium oxalate kidney stone.18 
The study showed that calcium supplementation with or without calcitriol did not 
increase AP(CaOx) significantly, (group C: AP(CaOx) 1.17+/-0.39 before treatment, 1.36+/- 
0.28 after treatment; group CD: 1.09+/- 0.17 before treatment, 1.09 +/-0.19 after treatment). 
They also calculated the AP(CaOx) value from 56 non-stone-forming normal women, where 
95% of normal values fell within a range of 1.05-1.52. Before treatment, there were three in 
group C and six in group CD that had an AP(CaOx) of greater than 1.52. After treatment there 
were six in group C and six in group CD who had AP(CaOx) more than 1.52. This finding is not 
significant. But there was a significant increase in urinary calcium excretion in group CD 
(baseline 2.87+/-0.41, after treatment 4.08+/-0.57). See Table II. Their study concluded that 
calcium supplementation does not increase the risk of calcium oxalate kidney stones in the 
“majority of postmenopausal women with osteoporosis”.16  
Sorensen et al Study 
This retrospective observational study17 with 7982 women evaluated whether or not 
dietary and supplemental calcium would decrease fractional calcium absorption. They also 
researched whether higher fractional calcium absorption was related to a higher incidence of 
kidney stones. The study population was primarily Caucasian women 65 years old or older. At 
the fourth visit, 5452 women were further evaluated for intestinal fractional calcium absorption. 
The study divided patients in 5 quintiles by their calcium supplementation dose. Within each 
quintile, patients were subdivided into two groups: with or without history of nephrolithiasis. 
Then each groups’ fractional calcium absorption was calculated and compared. This study shows 
that in each calcium supplement intake quintile, higher fractional calcium absorption is seen in 
populations with history of nephrolithiasis. Also, Sorensen et al17 found that “women were 30% 
more likely to report a history of nephrolithiasis for every 10% increase in fractional calcium 
absorption (OR 1.30, 95% CI 1.12-1.52, P<0.001)”. Moreover, in patients without a history of 
nephrolithiasis, the higher dietary and supplementary calcium intake, the lower the fractional 
calcium absorption rate was.17 See Table III.  
The study concluded that calcium supplement decreases fractional calcium absorption. 
Higher fractional calcium absorption is seen in patients with history of kidney stones. The 
authors concluded that calcium supplementation does not increase the risk of kidney stones, but 
on the contrary, may decrease the risk.17  
DISCUSSION 
              With the two studies,16,17 it is very difficult to make a direct comparison with each other 
due to a lot of reasons, such as the apparent different nature and characteristics of the study type, 
the different methods and endpoints used in both studies, the different population with different 
prognostic factors and etc. However, both studies point out that with calcium supplements, there 
is likely to be no increase in risk of kidney stones formation in postmenopausal women. 
Moreover the Sorensen et al17 study even concluded that calcium supplementation could protect 
against kidney stones. This could be due to that with calcium supplementation, there would be 
more combination of oxalate with calcium in the intestine, which in turn decreases the oxalate in 
the urine, and therefore decreases calcium oxalate kidney stone incidence.12,17,23 
              Moreover, kidney stone formation is a very complicated process with a lot of factors 
involved. Besides supplements, diet is another aspect worth considering. A diet called the DASH 
diet has been proven to decrease the supersaturation of calcium oxalate, and in turn decrease 
incidence of calcium oxalate kidney stones.24,25 The DASH diet is basically a diet high in fruit 
and vegetables, low in protein and salt, and moderate in low-fat dairy products.24,25 So as a 
clinician, clarifying the confusion and wrong impression that most patients had about calcium 
supplementation in postmenopausal women is very important. 
Limitation of  the Domrongkitchaiporn et al Trial 
The first study16 was randomized but without a real control group. Its AP(CaOx) value 
was compared with a baseline value calculated from 56 non-stone forming women with a 95% 
CI. The control group age was younger than the study group, average 36.7+/-1.8 yrs, verses the 
study group age average 65.3+/- 1.1 yrs. The total population sample size was very small and 
limited to the nationality of Thai women. Their dietary habits are not quite the same as the 
Western population. And the control group diet component was not discussed in the study. The 
use of AP(CaOx) as a surrogate endpoint of the study was a limitation instead of using patient 
reported kidney stone events as endpoint.  
The 3 months follow-up could also be a limitation. There is no study showing the length 
of study needed to understand kidney stone formation with all of its risk factors. Therefore there 
can be clinically significant events occurring after 3 months of follow-up, although in another 
study conducted by the Haghighi et al12, a 1 year follow up of 53 postmenopausal women with 
1000 mg calcium supplementation per day did not show any influence on kidney stone formation 
either. 
Dosage of supplementation is another issue. A calcium supplementation of 750 mg of 
calcium supplementation is lower than the current recommendation of 1200 mg in 
postmenapausal women. Could adding 450mg more of calcium per day can make a significant 
change in the result? 
The study’s timing of the calcium and calcitriol supplementation fixed at the end of the 
meal was the best possible scenario. This made up for the limitation of a similar previous study, 
Curhan et al26, in which timing of the calcium supplementation was not standardized. Curhan et 
al26 authors found that nonfood calcium supplementation has a higher risk of kidney stone 
formation compared to dietary calcium. However, in their discussion part, they suggested that 
this finding could be due to the timing of supplemental calcium ingestion not being strictly 
controlled. It is commonly thought that calcium supplementation is not recommended in patients 
with a history of nephrolithiasis. Curhan et al26 study showed that higher dietary intake of 
calcium as a matter of fact decreases the risk of kidney stone formation in women. 
Limitations of the Sorensen et al study 
             This study17 was unique in the way that it tried to find the relationship between intestinal 
calcium absorption and kidney stones. Although this study was retrospective with no control 
group, it provided a much bigger sample size. Most importantly, it used kidney stone as a clinical 
endpoint instead of using surrogate endpoint such as AP(CaOx) index or hypercalciuria, which 
correlated with but did not necessarily lead to kidney stones. However noticeably, 
Domrongkitchaiporn et al16 trial directly focused on risk of calcium oxalate kidney stones. 
Sorensen et al17 study did not differentiate the subtypes of kidney stones. Without going into too 
much details of different types of kidney stones and their compositions, there are uric acid 
kidney stones caused by metabolic disorder of high uric acid and struvite stones caused by 
urinary tract infections. The subtypes of stones should have been screened and discussed to 
ensure an accurate correlation between calcium supplementation and kidney stones.  
            Sorensen et al17 study also included patients on vitamin D supplements, estrogen, and 
thiazide diuretics, who were excluded in Domrongkitchaiporn et al16 study. Both vitamin D and 
thiazide use can alter calcium homeostasis. So in data analysis, authors used “multivariate 
logistic regression analysis” to adjust the variables.16 The data would be more reliable if the 
factors that could influence the calcium homeostasis are excluded from the study population. 
Overall, the quality of evidence for the association between calcium supplementation and risk of 
kidney stone formation is low (see Table  I).  
After reviewing these studies, having more RCTs done with longer follow up and larger 
sample sizes is recommended in order to increase the body of evidence for fully establishing the 
relationship between calcium supplementation and risk of calcium oxalate kidney stones. Also, 
the studies would be better if it had control group with similar prognostic factors. Moreover, 
using a direct outcome measure such as rate of kidney stone formation as an endpoint is 
recommended verses using surrogate endpoints.  
CONCLUSION 
According to current AACE recommendations, daily 1000-1200mg calcium is advised in 
postmenopausal women with osteoporosis. But some patients and even clinicians are concerned 
about the risk of calcium kidney stone formations with oral calcium supplementations. From the 
results of the two studies and data collected, calcium supplementation in postmenopausal women 
does not likely increase the risk of calcium oxalate kidney stones. Also postmenopausal patients 
who had an incidence of kidney stones in the past should not be discouraged from taking calcium 
supplements to prevent them from having osteoporosis.  
Furthermore, the DASH diet can be recommended to postmenopausal women. From the 
two studies discussed, dietary and supplemental calcium intake in these studies seems to actually 
decrease the risk of kidney stone formation. Clinicians and healthcare providers should feel 
comfortable recommending calcium supplementation in postmenopausal women with or without 
history of kidney stones to prevent them from the effects of osteoporosis.  
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Table I. Characteristics of Reviewed Studies 
 
Study Design Limitati
ons 
Indirect
ness 
Impreci
sion 
Inconsist
ency 
Publication 
bias likely 
Qualit
y 
Domrongkitch
aiporn et al16 
RCT Serious
a,b 
Not 
serous 
Seriousc Not 
serious 
No bias likely Low 
Sorensen et 
al17 
Observati
onal 
Serious
d 
Not 
serious 
Not 
serious 
Not 
serious 
No bias likely Very 
Low 
a No mention of level of blinding of study 
b Strong use of surrogate outcomes no control group 
c Small sample size 
d Lack of strong control group 
Table II. Summary of Findings a 
Domrongkitchaiporn et al16 Baseline  Post intervention 
outcome 
calcium 
supplement 
calcium+calcitriol 
supplement 
calcium 
supplement 
calcium+calcitriol 
supplement 
urine calcium 2.90+/-0.43 2.87+/-0.41 3.58+/-0.54 4.08+/-0.57 
urine oxalate 0.33+/-0.03 0.27+/-0.04 0.29+/-0.03 0.22+/-0.02 
AP(CaOx) 1.17+/-0.39 1.09+/-0.17 1.36+/-0.28 1.09+/-0.19 
 
 
Table III. Summary of Findings b 
Sorensen et al study17 current calcium supplementation dose mean calcium absorption 
fractional calcium absorption none <480mg 481-720mg 
721-
1200mg >1200mg 
no nephrolithiasis history 
33.4+/-
7.7 32.6+/-7.4 32.3+/-7.5 31.7+/-7.5 31.1+/-7.4 
nephrolithiasis history 
35.2+/-
8.4 33.8+/-7.8 31.9+/-8.7 32.7+/-7.1 32.8+/-7.8 
 
 
 
